Publication | Closed Access

Differences in the eyelid and buccal microbiome of glaucoma patients receiving long-term administration of prostaglandin analog drops

Buccal MicrobiomeOcular DiseaseProstaglandin Analog DropsOphthalmologyMedicineGlaucomaInfection ControlMicrobiologyOcular PharmacologyMicrobiomeAqueous HumourClinical MicrobiologyAntimicrobial ResistanceGlaucoma Patients